鼻咽内超声引导经鼻咽针吸活检诊断鼻咽癌放化疗后黏膜下复发
本研究评估鼻咽内超声引导经鼻咽针吸活检(ENUS-TNNA)对放化疗后疑似鼻咽癌黏膜下复发患者的安全性和有效性。2017年3月至2021年6月共11例患者接受ENUS-TNNA,全部操作无穿刺相关事件,9例经组织病理或细胞学确诊黏膜下复发,无严重并发症。结论认为ENUS-TNNA是获取鼻咽黏膜下组织样本的安全、有效、微创方法。
要点
- ENUS-TNNA对疑似鼻咽癌黏膜下复发取材安全,11例均无穿刺相关事件。
- 11例中9例经组织病理或细胞学确诊黏膜下复发。
- 2例穿刺阴性者中1例随访3年无癌,另1例手术活检诊断为放疗后血管肉瘤。
核心结论
- ENUS-TNNA是获取疑似鼻咽癌复发患者鼻咽黏膜下组织样本的安全、有效、微创方法。
研究设计与样本
- 单中心研究,2017年3月至2021年6月纳入11例放化疗后MRI疑似鼻咽癌黏膜下复发的患者,均接受ENUS-TNNA。
主要发现
- 所有11例针吸活检操作均无穿刺相关事件发生。
- 11例中9例经组织病理或细胞学评估诊断为鼻咽癌黏膜下复发。
- 2例穿刺阴性者中,1例因影像和临床表现不典型予MRI随访,3年后黏膜下病灶缩小仍认为无癌。
- 另1例穿刺阴性者经手术方法获取黏膜下活检样本,病理检查发现放疗后发生的血管肉瘤。
- ENUS-TNNA操作过程中无严重并发症发生。
关键数值与推荐
- 11例疑似鼻咽癌黏膜下复发患者接受ENUS-TNNA,9例经组织病理或细胞学确诊复发。
- 2例穿刺阴性,其中1例随访3年无癌,1例手术活检诊断为放疗后血管肉瘤。
- 操作无穿刺相关事件,无严重并发症。
临床怎么用
- 对放化疗后MRI疑似鼻咽癌黏膜下复发且组织取材困难者,可考虑ENUS-TNNA获取病理以指导治疗决策。
- 穿刺阴性者需结合影像随访或手术活检进一步明确诊断,警惕放疗后第二原发肿瘤。
局限性
- 样本量小(11例),为单中心研究。
- 原文未报告敏感性、特异性等诊断效能指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrence of nasopharyngeal carcinoma (NPC) after chemoradiotherapy is common, but submucosal recurrence of NPC is rare. The final pathological results determine the optimal therapeutic schedule for treatment of NPC recurrence, but tissue retrieval from submucosal lesions is usually difficult. The present study aimed to assess the safety and efficacy of a novel approach of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration (ENUS-TNNA) for submucosal neoplasms in patients with suspected NPC recurrence. METHODS: Between March 2017 and June 2021, 11 post-chemoradiotherapy patients with suspected magnetic resonance imaging (MRI) findings of submucosal recurrence of NPC underwent ENUS-TNNA. The safety and effectiveness of using ENUS-TNNA to sample submucosal neoplasms were evaluated. RESULTS: Needle aspiration biopsies were performed without any incidences in all cases. Out of the 11 patients, nine were diagnosed with submucosal recurrence of NPC via histopathological or cytological evaluations. Of the two puncture-negative cases, one patient had atypical imaging findings and clinical manifestations and was therefore followed-up using MRI. After follow-up for 3 years, this patient was still considered to be cancer-free due to the shrinking diameters of the submucosal lesions. For the other puncture-negative patient, submucosal biopsy samples were obtained using a surgical method. Pathological examination of these biopsies revealed that an angiosarcoma had developed after radiotherapy. There were no severe complications that occurred during the ENUS-TNNA procedure. CONCLUSION: ENUS-TNNA is a safe, effective, and minimally invasive approach to obtain tissue samples from the submucosal region of the nasopharynx for patients with suspected NPC recurrence.
引用
- Zhang ZM, Zhao R, Bao Y, et al. A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy. Radiother Oncol. 2021. PMID: 34627938. doi:10.1016/j.radonc.2021.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。